Systemic inflammatory response syndrome
- 1 July 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 84 (7) , 920-935
- https://doi.org/10.1002/bjs.1800840707
Abstract
Background: Localized inflammation is a physiological protective response which is generally tightly controlled by the body at the site of injury. Loss of this local control or an overly activated response results in an exaggerated systemic response which is clinically identified as systemic inflammatory response syndrome (SIRS). Compensatory mechanisms are initiated in concert with SIRS and outcome (resolution, multiple organ dysfunction syndrome or death) is dependent on the balance of SIRS and such compensatory mechanisms. No directed therapies have been successful to date in influencing outcome. Method: This review examines the current spectrum and pathophysiology of SIRS. Results and conclusion: Further clinical and basic scientific research is required to develop the global picture of SIRS, its associated family of syndromes and their natural histories.Keywords
This publication has 143 references indexed in Scilit:
- Immunonutrition and enteral hyperalimentation of critically ill patientsDigestive Diseases and Sciences, 1992
- Endothelial cell mediators of thrombosis and fibrinolysisCoronary Artery Disease, 1991
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxinBiochemical and Biophysical Research Communications, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987